Management of scleral melt

Bennett E. Ahearn, Kathryn E. Lewis, Blair E. Reynolds, Ahmad Kheirkhah

Producción científica: Review articlerevisión exhaustiva


Scleral melting, while rare, can lead to significant ocular morbidity. Several possible risk factors for scleral melt have been identified, such as infection, autoimmune disease, trauma, and post-surgical state, and these may act in combination with each other. Treatment should be tailored according to the etiology and severity of the scleral melt. Medical management may be indicated, especially in cases of autoimmune-related melt; however, surgical procedures are often necessary due to compromised ocular integrity and limited penetration of medications into the avascular sclera. An understanding of the surgical options available and their operative outcomes is particularly important when choosing the appropriate treatment protocol for each patient.

Idioma originalEnglish (US)
Páginas (desde-hasta)92-99
Número de páginas8
PublicaciónOcular Surface
EstadoPublished - ene 2023

ASJC Scopus subject areas

  • Ophthalmology


Profundice en los temas de investigación de 'Management of scleral melt'. En conjunto forman una huella única.

Citar esto